229 related articles for article (PubMed ID: 9918559)
1. Sustained desensitization of hypothalamic 5-Hydroxytryptamine1A receptors after discontinuation of fluoxetine: inhibited neuroendocrine responses to 8-hydroxy-2-(Dipropylamino)Tetralin in the absence of changes in Gi/o/z proteins.
Raap DK; Garcia F; Muma NA; Wolf WA; Battaglia G; van de Kar LD
J Pharmacol Exp Ther; 1999 Feb; 288(2):561-7. PubMed ID: 9918559
[TBL] [Abstract][Full Text] [Related]
2. Daily injections of fluoxetine induce dose-dependent desensitization of hypothalamic 5-HT1A receptors: reductions in neuroendocrine responses to 8-OH-DPAT and in levels of Gz and Gi proteins.
Raap DK; Evans S; Garcia F; Li Q; Muma NA; Wolf WA; Battaglia G; Van De Kar LD
J Pharmacol Exp Ther; 1999 Jan; 288(1):98-106. PubMed ID: 9862759
[TBL] [Abstract][Full Text] [Related]
3. Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: reductions in hypothalamic and midbrain Gi and G(o) proteins and in neuroendocrine responses to a 5-HT1A agonist.
Li Q; Muma NA; van de Kar LD
J Pharmacol Exp Ther; 1996 Nov; 279(2):1035-42. PubMed ID: 8930214
[TBL] [Abstract][Full Text] [Related]
4. Destruction of serotonergic nerve terminals prevents fluoxetine-induced desensitization of hypothalamic 5-HT(1A) receptors.
D'Souza DN; Zhang Y; Garcia F; Battaglia G; Van De Kar LD
Psychopharmacology (Berl); 2002 Dec; 164(4):392-400. PubMed ID: 12457269
[TBL] [Abstract][Full Text] [Related]
5. A desensitization of hypothalamic 5-HT1A receptors by repeated injections of paroxetine: reduction in the levels of G(i) and G(o) proteins and neuroendocrine responses, but not in the density of 5-HT1A receptors.
Li Q; Muma NA; Battaglia G; Van de Kar LD
J Pharmacol Exp Ther; 1997 Sep; 282(3):1581-90. PubMed ID: 9316875
[TBL] [Abstract][Full Text] [Related]
6. Coadministration of 5-hydroxytryptamine(1A) antagonist WAY-100635 prevents fluoxetine-induced desensitization of postsynaptic 5-hydroxytryptamine(1A) receptors in hypothalamus.
Serres F; Muma NA; Raap DK; Garcia F; Battaglia G; Van de Kar LD
J Pharmacol Exp Ther; 2000 Jul; 294(1):296-301. PubMed ID: 10871325
[TBL] [Abstract][Full Text] [Related]
7. Fluoxetine-induced changes in body weight and 5-HT1A receptor-mediated hormone secretion in rats on a tryptophan-deficient diet.
D'Souza DN; Zhang Y; Garcia F; Battaglia G; Van de Kar LD
Am J Physiol Regul Integr Comp Physiol; 2004 Feb; 286(2):R390-7. PubMed ID: 14604841
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the functional heterologous desensitization of hypothalamic 5-HT(1A) receptors after 5-HT(2A) receptor activation.
Zhang Y; D'Souza D; Raap DK; Garcia F; Battaglia G; Muma NA; Van de Kar LD
J Neurosci; 2001 Oct; 21(20):7919-27. PubMed ID: 11588165
[TBL] [Abstract][Full Text] [Related]
9. Treatment of cycling female rats with fluoxetine induces desensitization of hypothalamic 5-HT(1A) receptors with no change in 5-HT(2A) receptors.
Van de Kar LD; Raap DK; Battaglia G; Muma NA; Garcia F; DonCarlos LL
Neuropharmacology; 2002 Jul; 43(1):45-54. PubMed ID: 12213258
[TBL] [Abstract][Full Text] [Related]
10. Estradiol accelerates the effects of fluoxetine on serotonin 1A receptor signaling.
Li Q; Sullivan NR; McAllister CE; Van de Kar LD; Muma NA
Psychoneuroendocrinology; 2013 Jul; 38(7):1145-57. PubMed ID: 23219224
[TBL] [Abstract][Full Text] [Related]
11. Evidence that G(z)-proteins couple to hypothalamic 5-HT(1A) receptors in vivo.
Serres F; Li Q; Garcia F; Raap DK; Battaglia G; Muma NA; Van de Kar LD
J Neurosci; 2000 May; 20(9):3095-103. PubMed ID: 10777773
[TBL] [Abstract][Full Text] [Related]
12. Estrogen desensitizes 5-HT(1A) receptors and reduces levels of G(z), G(i1) and G(i3) proteins in the hypothalamus.
Raap DK; DonCarlos L; Garcia F; Muma NA; Wolf WA; Battaglia G; Van de Kar LD
Neuropharmacology; 2000 Jul; 39(10):1823-32. PubMed ID: 10884563
[TBL] [Abstract][Full Text] [Related]
13. Alterations in 8-hydroxy-2-(dipropylamino)tetralin-induced neuroendocrine responses after 5,7-dihydroxytryptamine-induced denervation of serotonergic neurons.
Van de Kar LD; Li Q; Cabrera TM; Brownfield MS; Battaglia G
J Pharmacol Exp Ther; 1998 Jul; 286(1):256-62. PubMed ID: 9655867
[TBL] [Abstract][Full Text] [Related]
14. Ovariectomy-induced increases in hypothalamic serotonin-1A receptor function in rats are prevented by estradiol.
Raap DK; DonCarlos LL; Garcia F; Zhang Y; Muma NA; Battaglia G; Van de Kar LD
Neuroendocrinology; 2002 Dec; 76(6):348-56. PubMed ID: 12566942
[TBL] [Abstract][Full Text] [Related]
15. Estrogen reduces serotonin-1A receptor-mediated oxytocin release and Galpha(i/o/z) proteins in the hypothalamus of ovariectomized rats.
D'Souza DN; Zhang Y; Damjanoska KJ; Carrasco GA; Sullivan NR; Garcia F; Battaglia G; Doncarlos LL; Muma NA; Van de Kar LD
Neuroendocrinology; 2004; 80(1):31-41. PubMed ID: 15385710
[TBL] [Abstract][Full Text] [Related]
16. Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats.
Li Q; Levy AD; Cabrera TM; Brownfield MS; Battaglia G; Van de Kar LD
Brain Res; 1993 Dec; 630(1-2):148-56. PubMed ID: 8118681
[TBL] [Abstract][Full Text] [Related]
17. Rapid desensitization of 5-HT(1A) receptors in Fawn-Hooded rats after chronic fluoxetine treatment.
Kantor S; Graf M; Anheuer ZE; Bagdy G
Eur Neuropsychopharmacol; 2001 Feb; 11(1):15-24. PubMed ID: 11226808
[TBL] [Abstract][Full Text] [Related]
18. WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion.
Vicentic A; Li Q; Battaglia G; Van de Kar LD
Eur J Pharmacol; 1998 Apr; 346(2-3):261-6. PubMed ID: 9652368
[TBL] [Abstract][Full Text] [Related]
19. Autoradiographic evidence for differential G-protein coupling of 5-HT1A receptors in rat brain: lack of effect of repeated injections of fluoxetine.
Li Q; Battaglia G; Van de Kar LD
Brain Res; 1997 Sep; 769(1):141-51. PubMed ID: 9374282
[TBL] [Abstract][Full Text] [Related]
20. The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.
Rasmussen K; Calligaro DO; Czachura JF; Dreshfield-Ahmad LJ; Evans DC; Hemrick-Luecke SK; Kallman MJ; Kendrick WT; Leander JD; Nelson DL; Overshiner CD; Wainscott DB; Wolff MC; Wong DT; Branchek TA; Zgombick JM; Xu YC
J Pharmacol Exp Ther; 2000 Aug; 294(2):688-700. PubMed ID: 10900249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
